RESUMEN
Background and Purpose: Poststroke aphasia has a major impact on peoples' quality of life. Speech and language therapy interventions work, especially in high doses, but these doses are rarely achieved outside of research studies. Intensive Comprehensive Aphasia Programs (ICAPs) are an option to deliver high doses of therapy to people with aphasia over a short period of time. Methods: Forty-six people with aphasia in the chronic stage poststroke completed the ICAP over a 3-week period, attending for 15 days and averaging 6 hours of therapy per day. Outcome measures included the Comprehensive Aphasia Test, an impairment-based test of the 4 main domains of language (speaking, writing, auditory comprehension, and reading) which was measured at 3 time points (baseline, immediately posttreatment at 3 weeks and follow-up at 12-week post-ICAP); and, the Communicative Effectiveness Index, a carer-reported measure of functional communication skills collected at baseline and 12 weeks. Results: A 2-way repeated measures multivariate ANOVA was conducted. We found a significant domain-by-time interaction, F=12.7, P<0.0005, indicating that the ICAP improved people with aphasia's language scores across all 4 domains, with the largest gains in speaking (Cohen's d=1.3). All gains were maintained or significantly improved further at 12-week post-ICAP. Importantly, patients' functional communication, as indexed by changes on the Communicative Effectiveness Index, also significantly improved at 12-week post-ICAP, t=5.4, P<0.0005, also with a large effect size (Cohen's d=0.9). Conclusions: People with aphasia who participated in the Queen Square ICAP made large and clinically meaningful gains on both impairment-based and functional measures of language. Gains were sustained and in some cases improved further over the subsequent 12 weeks.
Asunto(s)
Afasia/etiología , Afasia/terapia , Rehabilitación de Accidente Cerebrovascular , Accidente Cerebrovascular/complicaciones , Enfermedad Crónica , Comunicación , Comprensión , Femenino , Estudios de Seguimiento , Escritura Manual , Humanos , Pruebas del Lenguaje , Masculino , Persona de Mediana Edad , Calidad de Vida , Lectura , Habla , Logopedia , Resultado del TratamientoRESUMEN
OBJECTIVE: Parkinson's disease is associated with high rates of depression. There is growing interest in non-pharmacological management including psychological approaches such as Cognitive Behaviour Therapy. To date, little research has investigated whether processes that underpin cognitive models of depression, on which such treatment is based, apply in patients with Parkinson's disease. The study aimed to investigate the contribution of core psychological factors to the presence and degree of depressive symptoms. METHODS: 104 participants completed questionnaires measuring mood, motor disability and core psychological variables, including maladaptive assumptions, rumination, cognitive-behavioural avoidance, illness representations and cognitive-behavioural responses to symptoms. RESULTS: Regression analyses revealed that a small number of psychological factors accounted for the majority of depression variance, over and above that explained by overall disability. Participants reporting high levels of rumination, avoidance and symptom focusing experienced more severe depressive symptoms. In contrast, pervasive negative dysfunctional beliefs did not independently contribute to depression variance. CONCLUSION: Specific cognitive (rumination and symptom focusing) and behavioural (avoidance) processes may be key psychological markers of depression in Parkinson's disease and therefore offer important targets for tailored psychological interventions.
Asunto(s)
Afecto , Reacción de Prevención , Depresión/psicología , Personas con Discapacidad/psicología , Enfermedad de Parkinson/psicología , Desempeño Psicomotor , Anciano , Terapia Cognitivo-Conductual , Depresión/terapia , Femenino , Humanos , Masculino , Persona de Mediana Edad , AutoinformeRESUMEN
Positive perceptions of illness are typically associated with good health outcomes. However, this may not be true for all domains of illness perception in neurodegenerative diseases because of their progressive incurable nature. The appropriateness of current measures of illness belief in these conditions is not known. The validity and reliability of the Illness Perception Questionnaire-Revised was evaluated in 215 participants with Parkinson's disease. A confirmatory factor analysis supported the structure of the Illness Perception Questionnaire-Revised with the exception of the treatment control domain. It is important to consider the nature of neurodegenerative diseases and limits of symptom control when planning interventions.
Asunto(s)
Conocimientos, Actitudes y Práctica en Salud , Enfermedad de Parkinson/psicología , Psicometría/instrumentación , Encuestas y Cuestionarios/normas , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Reproducibilidad de los ResultadosRESUMEN
Patients with semantic dementia (SD) show relative preservation of number skills, contrasting with their severe multimodal semantic impairment. Underpinning this preservation, it is argued, is spared understanding of numerical quantity, a competence likened to a spatial map and subserved by the parietal lobes. The study investigated quantity knowledge in 14 SD patients to determine whether it is consistently preserved irrespective of disease severity or whether there are constraints on this preserved knowledge domain. Performance was well preserved on Piagetian conservation tasks, estimating object numerosity, and understanding of basic numerical magnitude. However, patients showed impairment on real-world estimation tasks, increasing with semantic severity. More surprisingly, on an analogue scale task, they produced implausible responses, suggesting degraded knowledge of precise numerical relationships. The findings challenge the view that knowledge of quantity is totally preserved in SD and suggest that the temporal lobes have a contributory role in the conceptual understanding of quantity.
Asunto(s)
Comprensión , Degeneración Lobar Frontotemporal/psicología , Conceptos Matemáticos , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Conocimiento , Masculino , Persona de Mediana Edad , Desempeño Psicomotor , SemánticaRESUMEN
Arithmetic skills are generally claimed to be preserved in semantic dementia (SD), suggesting functional independence of arithmetic knowledge from other aspects of semantic memory. However, in a recent case series analysis we showed that arithmetic performance in SD is not entirely normal. The finding of a direct association between severity of patients' semantic disorder and arithmetic impairment pointed to a closer relationship between semantic memory and arithmetic knowledge than previously acknowledged. The present study aimed to determine whether arithmetic performance in SD is subject to the same influences as has been found in other semantic domains, namely an autobiographical effect. SD patients were assessed on their ability to perform arithmetic in personally relevant compared to non-personal contexts. Patients who were regular, current followers of the television game show Countdown performed better on a simplified version of the show's number game compared to a conventional written calculation task, whereas patients with no experience of Countdown demonstrated the opposite pattern. SD patients showed better knowledge of multiplication table 'facts' when these were embedded in a situation relevant to their daily lives compared to a non-personal arithmetic task. They also performed better on a written calculation task when problems were presented as a monetary transaction compared to a standard arithmetic problem. A reference group of patients with Alzheimer's disease (AD) showed the reverse pattern. The findings provide convincing evidence that autobiographical relevance influences SD patients' arithmetic performance. Moreover, they challenge current views on conceptual number knowledge as a unitary, abstract competence.
Asunto(s)
Degeneración Lobar Frontotemporal/fisiopatología , Degeneración Lobar Frontotemporal/psicología , Acontecimientos que Cambian la Vida , Matemática , Solución de Problemas , Anciano , Enfermedad de Alzheimer/fisiopatología , Enfermedad de Alzheimer/psicología , Estudios de Cohortes , Comprensión/fisiología , Femenino , Humanos , Individualidad , Masculino , Persona de Mediana Edad , Pruebas Neuropsicológicas , Estadísticas no ParamétricasRESUMEN
Variation in the clinical characteristics of patients with Alzheimer's disease (AD) is increasingly recognised, although the factors underlying variation are not fully understood. The study examined the cognitive characteristics of 523 AD patients at the time of their presentation to a neurological dementia clinic and explored the relationship to family history and apolipoprotein E (APOE) genotype. Distinct profiles were identified, which were mirrored by topographical differences on neuroimaging. Clinical distinctions were maintained over time. Two-thirds of patients showed a constellation of deficits at presentation which included memory, language, visuospatial and constructional difficulties. However, a quarter had circumscribed presentations of amnesia, aphasia, perceptuospatial disorder or apraxia. The rare presence of frontal lobe characteristics was associated with a younger age of onset, an increased incidence of myoclonus at presentation, a positive family history but not with possession of APOE epsilon4 allele. An amnestic presentation (severe, yet circumscribed amnesia) was strongly associated with an older age of onset, a positive family history and the presence of APOE epsilon4 allele. Posterior cortical presentations showed a female bias, were typically sporadic, and showed no association with APOE epsilon4. The findings support the notion of phenotypic variation in AD, and show that genetic risk factors can influence clinical presentation. The findings draw attention to the specific association between APOE epsilon4 allele and memory but challenge the commonly held notion that the presence of the epsilon4 allele inevitably reduces onset age. The findings indicate that risk factors other than APOE epsilon4 allele underlie the non-familial, early onset posterior hemisphere presentations of AD.
Asunto(s)
Enfermedad de Alzheimer/genética , Apolipoproteína E4/genética , Trastornos del Conocimiento/complicaciones , Lóbulo Frontal/patología , Predisposición Genética a la Enfermedad , Adulto , Edad de Inicio , Anciano , Enfermedad de Alzheimer/clasificación , Enfermedad de Alzheimer/complicaciones , Enfermedad de Alzheimer/patología , Enfermedades de los Ganglios Basales/complicaciones , Enfermedades de los Ganglios Basales/genética , Enfermedades de los Ganglios Basales/patología , Trastornos del Conocimiento/genética , Femenino , Humanos , Masculino , Persona de Mediana Edad , Linaje , Fenotipo , Factores de Riesgo , Estadísticas no ParamétricasRESUMEN
The age distribution of the epsilon4 allelic form of the apolipoprotein E gene (APOE) was investigated in 630 patients with Alzheimer's disease (AD) with onset age ranging from 35 to 90 years. Overall, mean age at onset in APOE epsilon4 allele bearers was significantly later than that in nonbearers. However, when stratified into early onset AD (EOAD) and late onset (LOAD) groups, mean age at onset in EOAD cases bearing APOE epsilon4 allele was later than that in those EOAD cases without epsilon4 allele, whereas in LOAD mean age at onset in cases bearing APOE epsilon4 allele was earlier than in those without epsilon4 allele. When analysed by decade, it was observed that 37% of the total number of APOE epsilon4 allele bearers, and 43% of total number of cases with APOE epsilon4/epsilon4 genotype fell into the 60-69 years age class. Hence, APOE epsilon4 allele frequency, at 0.44, was highest in the 60-69 years age class, progressively decreasing either side of this age group. APOE epsilon4 allele therefore has its maximum impact between onset ages of between 60 and 70 years.
Asunto(s)
Enfermedad de Alzheimer/epidemiología , Enfermedad de Alzheimer/genética , Apolipoproteína E4/genética , Frecuencia de los Genes/genética , Edad de Inicio , Anciano , Anciano de 80 o más Años , Trastornos del Conocimiento/diagnóstico , Trastornos del Conocimiento/epidemiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pruebas Neuropsicológicas , Índice de Severidad de la EnfermedadRESUMEN
BACKGROUND: Psychiatric symptoms are a common feature of Huntington's disease (HD) and often precede the onset of motor and cognitive impairments. However, it remains unclear whether psychiatric changes in the preclinical period result from structural change, are a reaction to being at risk or simply a coincidental occurrence. Few studies have investigated the temporal course of psychiatric disorder across the preclinical period. OBJECTIVES: To compare lifetime and current prevalence of psychiatric disorder in presymptomatic gene carriers and non-carriers and to examine the relationship of psychiatric prevalence in gene carriers to temporal proximity of clinical onset. METHODS: Lifetime and current psychiatric histories of 204 at risk individuals (89 gene carriers and 115 non-carriers) were obtained using a structured clinical interview, the Composite International Diagnostic Interview. Psychiatric disorders were classified using both standardised diagnostic criteria and a more subtle symptom based approach. Follow-up of gene carriers (n = 51) enabled analysis of the role of temporal proximity to clinical onset. RESULTS: Gene carriers and non-carriers did not differ in terms of the lifetime frequency of clinical psychiatric disorders or subclinical symptoms. However, gene carriers reported a significantly higher rate of current depressive symptoms. Moreover, the rate of depression increased as a function of proximity to clinical onset. CONCLUSIONS: Affective disorder is an important feature of the prodromal stages of HD. The findings indicate that depression cannot be accounted for by natural concerns of being at risk. There is evidence of a window of several years in which preclinical symptoms are apparent.
Asunto(s)
Heterocigoto , Enfermedad de Huntington/genética , Enfermedad de Huntington/psicología , Trastornos Mentales/epidemiología , Adulto , Estudios de Casos y Controles , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Pruebas Neuropsicológicas , Prevalencia , Factores de TiempoRESUMEN
We have investigated the pathological correlates of dementia in the brains from a consecutive series of 70 patients dying with a clinical diagnosis of frontotemporal lobar degeneration (FTLD). Clinical misdiagnosis rate was low with only 3 patients (4%) failing to show pathological changes consistent with this diagnosis; 1 patient had Alzheimer's disease and 2 had cerebrovascular disease (CVD). In the remaining 67 patients, the most common underlying histological cause was ubiquitin pathology with 24 (36%) cases so affected. In these, ubiquitin-positive inclusions were present in the cerebral cortex as small, rounded or crescent-shaped structures within the cytoplasm of neurones of layer II, together with coiled or curvilinear bodies within neurites, and in the hippocampus as small, solid and more spherical-shaped inclusion bodies within the cytoplasm of dentate gyrus granule cells. In one patient, "cat's eye" or "lentiform" intranuclear ubiquitin inclusions were also present. The second most common histological type was dementia lacking distinctive histology (DLDH), in which neither tau nor ubiquitin inclusions were present, with 16 cases (24%) being affected. Pick-type histology was seen in 14 cases (21%) and tau histological changes associated with frontotemporal dementia (FTD) linked to chromosome 17 (FTDP-17) were present in 11 cases (16%). One case (1%) showed an unusual tau pathology that could not be allocated to any of the other tau groups. Only 1 case (1%) had neuronal intermediate filament inclusion dementia. No cases with ubiquitinated, valosin-containing protein-immunoreactive intranuclear inclusion bodies of the type seen in inclusion body myopathy with Paget's disease of bone and frontotemporal dementia were seen. Clinicopathological correlation showed that any of these histological subtypes can be associated with FTD. However, for FTD with motor neurone disease (FTD+MND), semantic dementia or primary progressive aphasia (PA), the histological profile was either ubiquitin type or DLDH type; Pick-type histology was seen in only 1 case of PA. None of these latter three clinical subtypes was associated with a mutation in tau gene and FTDP-17 type of tau pathology. All cases of progressive apraxia were associated with Pick-type histology. Present data therefore indicate that, although ubiquitin pathology is the most common histological form associated with FTLD, this pathology is not tightly linked with, nor is pathologically diagnostic for, any particular clinical form of the disease, including FTD+MND.